Enfusion Inc
NYSE:ENFN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.78
10.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ENFN stock under the Base Case scenario is 9.38 USD. Compared to the current market price of 10.36 USD, Enfusion Inc is Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Enfusion Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ENFN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Enfusion Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Enfusion Inc
Balance Sheet Decomposition
Enfusion Inc
Current Assets | 85.4m |
Cash & Short-Term Investments | 48.3m |
Receivables | 32.2m |
Other Current Assets | 5m |
Non-Current Assets | 49.5m |
PP&E | 39.4m |
Other Non-Current Assets | 10.1m |
Current Liabilities | 23.6m |
Accounts Payable | 1.2m |
Accrued Liabilities | 22.4m |
Non-Current Liabilities | 41.4m |
Other Non-Current Liabilities | 41.4m |
Earnings Waterfall
Enfusion Inc
Revenue
|
195.2m
USD
|
Cost of Revenue
|
-64.1m
USD
|
Gross Profit
|
131.1m
USD
|
Operating Expenses
|
-124.3m
USD
|
Operating Income
|
6.8m
USD
|
Other Expenses
|
-3.4m
USD
|
Net Income
|
3.3m
USD
|
Free Cash Flow Analysis
Enfusion Inc
USD | |
Free Cash Flow | USD |
ENFN Profitability Score
Profitability Due Diligence
Enfusion Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
Score
Enfusion Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
ENFN Solvency Score
Solvency Due Diligence
Enfusion Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Enfusion Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENFN Price Targets Summary
Enfusion Inc
According to Wall Street analysts, the average 1-year price target for ENFN is 10.05 USD with a low forecast of 8.59 USD and a high forecast of 11.55 USD.
Dividends
Current shareholder yield for ENFN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ENFN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.
Contact
IPO
Employees
Officers
The intrinsic value of one ENFN stock under the Base Case scenario is 9.38 USD.
Compared to the current market price of 10.36 USD, Enfusion Inc is Overvalued by 9%.